Nonpronuclear- and Monopronuclear-derived Blastocysts Do Not Impair Subsequent Perinatal and Maternal Outcomes.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Qiuyu Xu, Xiaoyan Mao, Jie Zhang, Ling Wu
{"title":"Nonpronuclear- and Monopronuclear-derived Blastocysts Do Not Impair Subsequent Perinatal and Maternal Outcomes.","authors":"Qiuyu Xu, Xiaoyan Mao, Jie Zhang, Ling Wu","doi":"10.1210/clinem/dgae375","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The routine clinical practice is to prioritize the transfer of blastocysts derived from 2 pronuclei (2PN) embryos if they are available. For women who only have blastocysts resulting from nonpronuclear (0PN) and monopronuclear (1PN) embryos, whether to transfer these embryos or discard them has been an ongoing debate over the years.</p><p><strong>Objective: </strong>To investigate the perinatal and obstetric outcomes following the transfer of vitrified-warmed single blastocysts derived from 0PN and 1PN zygotes.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>University-affiliated in vitro fertilization center.</p><p><strong>Patient(s): </strong>This study included singletons born to women who had undergone 0PN and 1PN vitrified-warmed single blastocyst transfers, compared to those resulting from 2PN vitrified-warmed single blastocyst transfers from 2012 to 2021.</p><p><strong>Interventions: </strong>None.</p><p><strong>Main outcome measure(s): </strong>Perinatal and obstetric outcomes.</p><p><strong>Result(s): </strong>A total of 7284 women were included in the final analysis. Of these, 386, 316, and 6582 cycles resulted from 0PN-, 1PN-, and 2PN-derived blastocysts transfer, respectively. The rates of clinical pregnancy, miscarriage, and live birth were similar across the study cohorts in both unadjusted and adjusted analyses. When comparing the 0PN and 2PN groups, no differences were found in birth outcomes after adjusting for confounders. Similarly, maternal complications and mode of delivery were comparable between these 2 study cohorts. Birth parameters were also similar between the 1PN and 2PN blastocyst groups, except for more male births in the 1PN cohort. Furthermore, a comparison between the 1PN and 2PN groups did not reveal any significant differences in maternal outcomes.</p><p><strong>Conclusion: </strong>The current study showed that the transfer of 0PN and 1PN blastocysts did not compromise reproductive outcomes or increase maternal and perinatal complications. This information is valuable for clinicians to counsel couples effectively and guide them in making informed decisions.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e953-e961"},"PeriodicalIF":5.0000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae375","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: The routine clinical practice is to prioritize the transfer of blastocysts derived from 2 pronuclei (2PN) embryos if they are available. For women who only have blastocysts resulting from nonpronuclear (0PN) and monopronuclear (1PN) embryos, whether to transfer these embryos or discard them has been an ongoing debate over the years.

Objective: To investigate the perinatal and obstetric outcomes following the transfer of vitrified-warmed single blastocysts derived from 0PN and 1PN zygotes.

Design: Retrospective cohort study.

Setting: University-affiliated in vitro fertilization center.

Patient(s): This study included singletons born to women who had undergone 0PN and 1PN vitrified-warmed single blastocyst transfers, compared to those resulting from 2PN vitrified-warmed single blastocyst transfers from 2012 to 2021.

Interventions: None.

Main outcome measure(s): Perinatal and obstetric outcomes.

Result(s): A total of 7284 women were included in the final analysis. Of these, 386, 316, and 6582 cycles resulted from 0PN-, 1PN-, and 2PN-derived blastocysts transfer, respectively. The rates of clinical pregnancy, miscarriage, and live birth were similar across the study cohorts in both unadjusted and adjusted analyses. When comparing the 0PN and 2PN groups, no differences were found in birth outcomes after adjusting for confounders. Similarly, maternal complications and mode of delivery were comparable between these 2 study cohorts. Birth parameters were also similar between the 1PN and 2PN blastocyst groups, except for more male births in the 1PN cohort. Furthermore, a comparison between the 1PN and 2PN groups did not reveal any significant differences in maternal outcomes.

Conclusion: The current study showed that the transfer of 0PN and 1PN blastocysts did not compromise reproductive outcomes or increase maternal and perinatal complications. This information is valuable for clinicians to counsel couples effectively and guide them in making informed decisions.

非原核细胞和单核细胞来源的囊胚不会影响围产期和孕产妇的预后。
背景:常规临床实践是,如果有来自 2PN 胚胎的囊胚,则优先移植这些囊胚。对于只有由 0PN 和 1PN 胚胎产生的囊胚的妇女来说,是移植这些胚胎还是丢弃这些胚胎是多年来一直争论不休的问题:调查从 0PN 和 1PN 胚胎中提取的玻璃化温育单个囊胚移植后的围产期和产科结果:设计:回顾性队列研究:研究对象:大学附属试管婴儿中心:该研究包括2012年至2020年期间接受0PN和1PN玻璃化温育单囊胚移植的女性所生的单胎,并与接受2PN玻璃化温育单囊胚移植的女性所生的单胎进行比较:干预措施:无:主要结果测量指标:围产期和产科结果:共有 7284 名妇女被纳入最终分析。其中,0PN、1PN 和 2PN 胚泡移植周期分别为 386、316 和 6582 个。在未调整分析和调整分析中,各研究队列的临床妊娠率、流产率和活产率相似。在对混杂因素进行调整后,比较 0PN 组和 2PN 组的分娩结果未发现差异。同样,这两个研究队列的产妇并发症和分娩方式也不相上下。1PN 和 2PN 囊胚组之间的出生参数也相似,只是 1PN 组群中男婴出生率更高。此外,1PN 组和 2PN 组之间的比较也未发现产妇结局有任何显著差异:目前的研究表明,0PN 和 1PN 囊胚移植不会影响生育结果,也不会增加产妇和围产期并发症。这些信息对临床医生有效指导夫妇做出知情决定很有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信